Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-09-21 5:10 pm Purchase | 2023-09-19 | 13G | RayzeBio, Inc. Common Stock RYZB | VIKING GLOBAL INVESTORS LP | 6,642,700 10.900% | 6,642,700 (New Position) | Filing History |
| 2023-08-24 4:30 pm Purchase | 2023-08-14 | 13G | Valvoline Inc. VVV | VIKING GLOBAL INVESTORS LP | 8,338,456 6.000% | 8,338,456 (New Position) | Filing History |
| 2023-07-19 9:52 pm Sale | 2023-07-18 | 13D | BridgeBio Pharma, Inc. BBIO | VIKING GLOBAL INVESTORS LP | 25,120,991 15.700% | -1,500,000 (-5.63%) | Filing History |
| 2023-06-26 5:05 pm Sale | 2023-06-22 | 13G | Roivant Sciences Ltd. ROIV | VIKING GLOBAL INVESTORS LP | 75,238,700 9.900% | -13,000,000 (-14.73%) | Filing History |
| 2023-06-20 4:30 pm Purchase | 2023-06-07 | 13G | NewAmsterdam Pharma Company N.V. NAMS | VIKING GLOBAL INVESTORS LP | 6,524,565 7.980% | 6,524,565 (New Position) | Filing History |
| 2023-06-16 4:17 pm Unchanged | 2023-06-15 | 13D | Cazoo Group Ltd CZOO | VIKING GLOBAL INVESTORS LP | 30,000 7.200% | 0 (Unchanged) | Filing History |
| 2023-06-05 5:00 pm Purchase | 2023-05-26 | 13G | Verastem, Inc. VSTM | VIKING GLOBAL INVESTORS LP | 1,320,656 7.900% | 1,320,656 (New Position) | Filing History |
| 2023-05-16 5:27 pm Unchanged | 2023-05-12 | 13D | Cazoo Group Ltd CZOO | VIKING GLOBAL INVESTORS LP | 30,000 7.200% | 0 (Unchanged) | Filing History |
| 2023-04-27 4:30 pm Unchanged | 2023-04-25 | 13D | Cazoo Group Ltd CZOO | VIKING GLOBAL INVESTORS LP | 30,000 7.200% | 0 (Unchanged) | Filing History |
| 2023-03-21 4:46 pm Unchanged | 2023-03-17 | 13D | Cazoo Group Ltd CZOO | VIKING GLOBAL INVESTORS LP | 30,000 7.200% | 0 (Unchanged) | Filing History |
| 2023-02-27 5:10 pm Purchase | 2023-02-27 | 13D | Cazoo Group Ltd CZOO | VIKING GLOBAL INVESTORS LP | 30,000 7.200% | 30,000 (New Position) | Filing History |
| 2023-02-14 1:18 pm Purchase | 2022-12-31 | 13G | Pharvaris N.V. PHVS | VIKING GLOBAL INVESTORS LP | 3,231,923 9.700% | 776,387 (+31.62%) | Filing History |
| 2023-02-14 1:18 pm Sale | 2022-12-31 | 13G | Guardant Health, Inc. GH | VIKING GLOBAL INVESTORS LP | 4,107,644 4.000% | -1,014,851 (-19.81%) | Filing History |
| 2023-02-14 1:18 pm Sale | 2022-12-31 | 13G | Amylyx Pharmaceuticals, Inc. AMLX | VIKING GLOBAL INVESTORS LP | 4,634,606 7.000% | -1,135,930 (-19.68%) | Filing History |
| 2023-02-14 1:18 pm Purchase | 2022-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | VIKING GLOBAL INVESTORS LP | 6,162,362 9.990% | 177,628 (+2.97%) | Filing History |
| 2023-02-14 1:18 pm Purchase | 2022-12-31 | 13G | Inhibrx Biosciences, Inc. INBX | VIKING GLOBAL INVESTORS LP | 6,639,199 15.200% | 1,333,333 (+25.13%) | Filing History |
| 2023-02-14 1:18 pm Sale | 2022-12-31 | 13G | FIGS, Inc. FIGS | VIKING GLOBAL INVESTORS LP | 0 0.000% | -13,340,414 (Position Closed) | Filing History |
| 2023-02-14 1:18 pm Purchase | 2022-12-31 | 13G | APi Group Corporation APG | VIKING GLOBAL INVESTORS LP | 63,143,690 17.400% | 948,569 (+1.53%) | Filing History |
| 2023-02-14 1:18 pm Purchase | 2022-12-31 | 13G | Standard BioTools Inc. LAB | VIKING GLOBAL INVESTORS LP | 8,323,821 9.500% | 220,294 (+2.72%) | Filing History |
| 2023-02-14 1:18 pm Purchase | 2022-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | VIKING GLOBAL INVESTORS LP | 3,577,128 9.360% | 700,025 (+24.33%) | Filing History |